Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
Phase NA Withdrawn
Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer
Phase NA Withdrawn
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma
Phase 1 Withdrawn
Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
Phase 3 Withdrawn
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Withdrawn
Community Outreach-based Study to Increase Cervical Cancer Screening Among Hispanic Women in Cleveland
Withdrawn
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.
Phase 2 Withdrawn
A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer
Phase 2 Withdrawn
Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer
Phase NA Withdrawn
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Phase NA Withdrawn
CERAD-IMMUNE
Phase 2 Withdrawn
DELTA-2
Phase 1 Withdrawn
Curcumin in Advanced Cervical Cancer
Phase 2 Withdrawn
Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)
Phase 3 Withdrawn
Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women
Phase 2 Withdrawn
A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer
Phase 3 Withdrawn
HPV Vaccine in Postpartum Women
Withdrawn
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
Phase 1/2 Withdrawn
IRIS
Phase NA Withdrawn
Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer
Phase 1/2 Withdrawn
E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia
Phase 1 Withdrawn
Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes
Phase 2 Withdrawn
Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101
Phase 1 Withdrawn
MaRuC
Phase 2 Withdrawn
Improving Tumor Oxygenation in Cervical Cancer
Phase 2 Withdrawn
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
Phase 2 Withdrawn
Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer Patients
Phase 2 Withdrawn
Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
Phase 1 Withdrawn
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
Phase 1 Withdrawn
Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
Phase 2 Withdrawn
Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer
Withdrawn
Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
Phase 1/2 Withdrawn
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
Phase 2 Withdrawn
Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)
Phase 2 Withdrawn
Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults
Withdrawn
Ph Ib/BGJ398/Cervix and Other Solid Tumors
Phase 1 Withdrawn
The Value of Preoperative Sentinel Lymph Node Mapping by Pelvic MR Lymphangiography and SPECT-CT in Cervical Cancer
Withdrawn
Carotenoid Rich Diet in Treating Cervical Dysplasia
Phase 2 Withdrawn
Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer
Phase 1 Withdrawn
Prospective Evaluation of Intrafractional and Interfractional Cervical Motion During External Beam Radiation for Intact Cervical Cancer by the Calypso® 4D Localization System™
Withdrawn
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
Phase 1 Withdrawn
S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
Phase 3 Withdrawn
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer
Phase NA Withdrawn
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer
Phase 1 Withdrawn
New Indications for Ultrasound in the Staging of Cervical Cancer
Phase NA Withdrawn